与类药物过量服用相关的同时使用可和选择性血清素再吸收抑制剂
Sungho Bea1,2, Krista F Huybrechts1, Robert J Glynn1
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
BMC medicine
|November 29, 2025
概括
与塞特拉林相比,开始使用某些选择性血清素再吸收抑制剂 (SSRI) 与可一起增加了阿片类药物过量风险. 在citalopram,escitalopram,fluoxetine和paroxetine中,风险类似,这表明塞特拉林可能是更安全的选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 公共卫生 公共卫生
背景情况:
- 选择性血清素再吸收抑制剂 (SSRI) 经常与阿片类药物一起处方,引发了对药物相互作用的担忧.
- ,一种常见的阿片类药物,由CYP2D6和CYP3A4代谢,这些酶可以被SSRI抑制.
- 当与可联合处方时,不同SSRI与阿片类药物过量剂的比较风险尚不清楚.
研究的目的:
- 为了比较不同SSRI在可治疗期间开始治疗的患者中阿片类药物过量剂的风险.
- 为了确定与特定的SSRI (citalopram,escitalopram,fluoxetine,paroxetine,sertraline) 相关的过量风险的潜在差异.
主要方法:
- 一项基于人口的队列研究,使用美国医疗保险索赔数据 (2004-2022).
- 包括患者在服用可时启动五种SSRI之一.
- 过量服用阿片类药物被定义为住院或急诊室的访问.
- 倾向性得分匹配和加权的考克斯比例危险模型被用于分析.
主要成果:
- 超过140万名患者被纳入分析.
- 与塞特拉林相比,开始服用西塔洛普拉姆,埃斯基塔洛普拉姆,弗洛克塞或帕洛克塞与阿片类药物过量服用的风险更高.
- 危险比率 (vs. 谢特拉林) 是1.21 对于西塔洛普拉姆,1.19 对于埃斯基塔洛普拉姆,1.29 对于素,和1.17 对于帕罗素.
- 当与其他药物相比较时,没有发现citalopram,escitalopram,fluoxetine和paroxetine之间的显著风险差异.
结论:
- 与可一起开始服用西塔洛普拉姆,埃斯基塔洛普拉姆,可或帕洛克,与与塞特拉林相比,与阿片类药物过量风险的增加有关.
- 塞特拉林可能是需要与可联合处方的患者更安全的SSRI选择.
- 进一步的研究可以探索更安全的联合处方机制和临床指南.
相关概念视频
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
Antidepressant Drugs: MAOIs and Other Agents
774
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
774
Opioid Analgesics: Synthetic and Semisynthetic Opioids
888
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
888
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
609
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
609
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
479
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
479


